|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Amy | Amy | Eileen | 02-27279535 | 19F.-2, No.510, Sec. 5, Zhongsiao E. Rd., Xinyi Dist., Taipei CityTaiwan(R.O.C) | 2024/06/18 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | MEDICAL IMAGING CORPORATION, INC (MIC) provides medical consulting services and management in the field of Radiology, enabling hospitals to acquire state-of-the-art medical imaging modalities. MIC provides consultation in areas of sales coaching, technical training in medical device operation, and medical device maintenances. MIC has top-tier performances in sales operation. Since 2003, MIC is the exclusive distributor of Radiology medical devices for GE Healthcare Asia supplying high-end medical devices in Taiwan. By 2014, MIC expanded into China’s healthcare market and has since revolutionized China’s healthcare management. As of 2017, MIC has become the sole agent in Taiwan for GE-Sonazoid, an exclusively traded contrast agent for ultrasound. Our ultimate goal is to become top leaders in medical consulting services and management in the Asia-Pacific region. MIC will source out strategic partners to achieve scalable management. |
Market Information ( 2024/09/19 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
39.246 | 94.00 | 91.70 | 93.00 | 1.10 | 37 | .00 | N/A | N/A | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/09/19) |
TPEx measures adopted (2024/09/19) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |